All Documents


Events & Presentations

Investor Video

View Video

Press Releases

Sep 20, 2021
BeiGene Announces Inclusion in FTSE Russell Indices   
Sep 17, 2021
BeiGene Receives Positive CHMP Opinion for BRUKINSA® (Zanubrutinib) for the Treatment of Adults with Waldenström’s Macroglobulinemia    read more...
Sep 15, 2021
U.S. FDA Grants BRUKINSA® (Zanubrutinib) Accelerated Approval in Relapsed or Refractory Marginal Zone Lymphoma    read more...
Press Releases

Thank you for your interest in Beigene, Ltd ! You will receive an email shortly. Please confirm your email address by clicking the link inside.

Back to the form